CoLucid

CoLucid Pharmaceuticals is a biotechnology company focused on the treatment of central nervous system disorders. The company has developed COL-144, a neuroactive antimigraine drug designed to treat migraines; COL-204 is a conjugated cholinesterase platform capable of generating new chemical entities for the treatment of sleep/wake disorders, chronic pain, Alzheimer's disease, and psychiatric disorders.